Clinical Trial: A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential Hypertension

U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07660796) titled 'A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential Hypertension' on June 16.

Brief Summary: A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential Hypertension

Study Start Date: July 06

Study Type: INTERVENTIONAL

Condition: Hypertension

Intervention: DRUG: HCP1803-3

Test drug

DRUG: HCP1803-4

Test drug

DRUG: RLD2001-1

Control drug

DRUG: RLD2001-2

Control drug

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Hanmi Pharmaceutical Company Limited

Published by HT Digital Content Services with permission from Health Daily Digest....